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An orthodontist reads the previous piece in the Journal about investigating the prevalence of 
gingival recessions after orthodontic treatment (Papageorgiou, 2020). His curiosity is awoken and 
wants to check what would be the corresponding prevalence of post-orthodontic gingival 
recessions among his own patients. More importantly, following a recent talk in a scientific 
congress, he decided 5 years ago to change the treatment protocol for his non-extraction cases. 
He now prophylactically uses a free gingival graft on the labial side of incisors before starting 
treating cases with a very thin gingival biotype when arch expansion / protrusion has been 
planned. He therefore likes to see if this new treatment protocol is effective in preventing gingival 
recessions. 
He collects all non-extraction cases treated in his practice 4 years prior and 4 years after 
he implemented this new treatment protocol. He uses the detailed intraoral photographic 
documentation after treatment to assess the presence of at least one gingival recession and set 
this as his outcome. He finds 300 eligible patients from his archives, who are equally divided in 
the two treatment protocols. Among the 300 patients analysed, 99 (33%) of them have at least 
one recession after treatment and both groups seem to have similar prevalence of recession: 56 
out of 150 patients (37.3%) with the old protocol and 43 out of 150 patients (28.7%) with the new 
protocol (Table 1). He did a chi-square test to compare the proportion of patients with recessions 
in the two groups, which gave a P value of 0.11. Furthermore, he thought that the duration of 
orthodontic treatment might act as a confounder and might contribute to the development of 
recessions. He likewise extracted these data from the patient archives and compared them 
between groups. The overall median treatment duration for all patients was 24.1 months and this 
was similar in the two groups: 24.2 months in the old protocol and 24.1 months in the new protocol. 
As treatment duration was not normally distributed, he used a Mann-Whitney test to compare 
durations between groups, which gave him a P value of 0.70 
 
Which of the following statements are correct regarding the interpretation of the study’s 
results, if any: 
(A) No statistically significant difference exists in the development of gingival recessions with the 
two treatment protocols. 
(B) Treatment duration has been adequately handled as a confounder and cannot influence the 
study’s conclusions. 
(C) Treatment duration has no significant effect on the development of gingival recessions. 
(D) The risk for developing recessions according to this study sample is 33%, with no differences 
according to protocol and treatment duration. 
 
Discussion 
In order to correctly appraise the results of this study, one needs to first appraise how they were 
analysed. And the analytical strategy is heavily dependent from the type and nature of the 
observation we are talking about. In this instance the outcome data are binary – i.e. recession: 
yes or no. Therefore, a chi-squared test might be an appropriate first step to check for differences 
between the two protocols. 
Additionally, data are given about the duration of orthodontic treatment. This might be 
interesting, since intuitively duration might be associated with baseline malocclusion severity or 
with the oral health burden, thereby indirectly affecting recession risk. What is actually known 
about treatment duration for the included patients? We know that the average treatment duration 
is a sensible one (based on the orthodontic literature), as well as that the average treatment 
duration is similar in the two protocol groups and about 2 years. This does not mean however that 
all patients in the two groups had a 2-year (24-month) treatment. Looking carefully at the data, 
treatment duration varies considerably for the 300 studied patients: (i) the duration for 100 patients 
(33.3%) was up to 12.0 months, (ii) for 45 patients (15.0) was 12.1-24.0 months, (iii) for 99 (33.0%) 
patients was 24.1-36.0 months, and (iv) for 56 (18.7%) patients was >36.0 months. This is not to 
say that the two groups are different according to their distribution of these duration categories 
(they are not—the chi-squared P value is 0.28). But this indicates that the studied group is very 
heterogenous in terms of treatment duration. This is a common problem seen in retrospective 
studies that make use of routinely available material in sharp contrast to prospective randomized 
trials, where all patients might receive exactly (or almost exactly) the same exposure from an 
intervention – i.e. might be all consistently followed for 1 or 2 years. 
Given the big range of treatment duration (from 8.4 to 40.0 months) it is interesting to see 
how recessions develop within that timeframe. As can be seen in (Figure 1) more recessions are 
developed among the studied patients the longer the treatment takes. To put thing into 
perspective, the recession risk for durations <24.0 months is 34/140 (24.3%), while the recession 
risk for durations >24.0 months is 65/159 (40.9%). This can be modelled statistically giving a 
Relative Risk (RR) of 1.18 (95% Confidence Interval [CI]=1.07 to 1.29; P<0.001) per 6-month-
period, which means that for each additional 6 months of treatment duration the recession risk 
increases by 18%. Therefore, pooling simply all patients and analyzing them naively with a chi-
squared test as the orthodontist did, might not be the best treatment approach. 
Instead, a survival analysis taking into account the different times that a patient is 
‘exposed’ to the risk (i.e. the time in fixed-appliance treatment) might be more appropriate. Indeed, 
such an analysis gives a Hazard Ratio (HR) of 0.66 (95% CI=0.44 to 0.98) with a P value of 0.04. 
We see therefore that the new protocol is associated with a significantly reduced hazard for 
recession by 34%. If we plot this in similarly in a Kaplan-Meier survival curve (Figure 2), it is 
obvious that the two lines end up differently, particularly for longer treatment durations. This gives 
different results than the original analysis plan that was followed and therefore it is always 
important that such time-varying situations are appropriately tackled. 
To summarize, the conclusions of the original study might be misleading and (A) is wrong. 
Treatment duration was not properly handled in the original analysis and (B) is wrong. Treatment 
duration in this fictional example was significantly associated with baseline risk for recessions and 
(C) is wrong. And finally, the recession risk varied considerably according to both duration and 
treatment protocol. For durations <24.0 months recession rate was 25.7% and 22.9% for the old 
and new protocol, respectively. For durations >24.0 months recession rate was 48.1% and 33.8% 
for the old and new protocol, respectively, and (D) is wrong. 
 
Table 1. Results of the survey performed by the orthodontist. 
 Total Old protocol New 
protocol 
Test P 
Patients – n 300 150 150   











Recession – n (%) 99 (33.0%) 56 (37.3%) 43 (28.7%)   
Duration in months 










IQR, interquartile range. 
 
Figure 1. Kaplan-Meier survival curve for the whole sample. 
Figure 2. Kaplan-Meier survival curve separately for the two treatment protocols. 
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